These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17347554)

  • 21. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent biliary pseudolithiasis during ceftriaxone therapy.
    Heim-Duthoy KL; Caperton EM; Pollock R; Matzke GR; Enthoven D; Peterson PK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1146-9. PubMed ID: 2203305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary pseudolithiasis in childhood: a case report.
    Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B
    Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone-associated gallbladder pseudolithiasis: report of one case.
    Wen HH; Huang YK; Zheng GL
    Acta Paediatr Taiwan; 2004; 45(5):290-2. PubMed ID: 15868813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.
    Bonnet JP; Abid L; Dabhar A; Lévy A; Soulier Y; Blangy S
    Eur J Pediatr Surg; 2000 Dec; 10(6):368-71. PubMed ID: 11215777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.
    Kutuya N; Ozaki Y; Okazaki T
    J Med Ultrason (2001); 2008 Sep; 35(3):125-8. PubMed ID: 27278835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children.
    Kong MS; Chen CY
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):50-4. PubMed ID: 8935375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute urine retention induced by ceftriaxone.
    Akl KF; Masri AT; Hjazeen MM
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary sludge after liver transplantation: 1. Imaging findings and efficacy of various imaging procedures.
    Barton P; Maier A; Steininger R; Mühlbacher F; Lechner G
    AJR Am J Roentgenol; 1995 Apr; 164(4):859-64. PubMed ID: 7726038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ceftriaxone-induced cholelithiasis--a harmless side-effect?].
    Riccabona M; Kerbl R; Schwinger W; Spork D; Millner M; Grubbauer HM
    Klin Padiatr; 1993; 205(6):421-3. PubMed ID: 8309205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.
    Acun C; Erdem LO; Sogut A; Erdem CZ; Tomac N; Gundogdu S
    Pediatr Int; 2004 Jun; 46(3):368-70. PubMed ID: 15151561
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transient biliary lithiasis associated with the use of ceftriaxone].
    Alvarez-Coca González J; Cebrero García M; Vecilla Rivelles MC; Alonso Cristobo M; Torrijos Roman C
    An Esp Pediatr; 2000 Oct; 53(4):366-8. PubMed ID: 11083990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.